Intech Biopharm (Taiwan) Probability of Future Stock Price Finishing Over 26.88
| 6461 Stock | TWD 27.65 0.35 1.25% |
Intech |
Intech Biopharm Target Price Odds to finish over 26.88
The tendency of Intech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above NT$ 26.88 in 90 days |
| 27.65 | 90 days | 26.88 | roughly 96.0 |
Based on a normal probability distribution, the odds of Intech Biopharm to stay above NT$ 26.88 in 90 days from now is roughly 96.0 (This Intech Biopharm probability density function shows the probability of Intech Stock to fall within a particular range of prices over 90 days) . Probability of Intech Biopharm price to stay between NT$ 26.88 and its current price of NT$27.65 at the end of the 90-day period is about 13.5 .
Assuming the 90 days trading horizon Intech Biopharm has a beta of -0.079. This suggests as returns on the benchmark increase, returns on holding Intech Biopharm are expected to decrease at a much lower rate. During a bear market, however, Intech Biopharm is likely to outperform the market. Additionally Intech Biopharm has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Intech Biopharm Price Density |
| Price |
Predictive Modules for Intech Biopharm
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intech Biopharm. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Intech Biopharm Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Intech Biopharm is not an exception. The market had few large corrections towards the Intech Biopharm's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Intech Biopharm, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Intech Biopharm within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | -0.08 | |
σ | Overall volatility | 0.94 | |
Ir | Information ratio | -0.16 |
Intech Biopharm Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intech Biopharm for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intech Biopharm can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Intech Biopharm generated a negative expected return over the last 90 days | |
| Intech Biopharm has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 38.9 M. Net Loss for the year was (301.76 M) with loss before overhead, payroll, taxes, and interest of (119.37 M). | |
| Intech Biopharm generates negative cash flow from operations | |
| About 47.0% of the company shares are owned by insiders or employees |
Intech Biopharm Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intech Stock often depends not only on the future outlook of the current and potential Intech Biopharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intech Biopharm's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 116.3 M |
Intech Biopharm Technical Analysis
Intech Biopharm's future price can be derived by breaking down and analyzing its technical indicators over time. Intech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intech Biopharm. In general, you should focus on analyzing Intech Stock price patterns and their correlations with different microeconomic environments and drivers.
Intech Biopharm Predictive Forecast Models
Intech Biopharm's time-series forecasting models is one of many Intech Biopharm's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Intech Biopharm's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Intech Biopharm
Checking the ongoing alerts about Intech Biopharm for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Intech Biopharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Intech Biopharm generated a negative expected return over the last 90 days | |
| Intech Biopharm has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 38.9 M. Net Loss for the year was (301.76 M) with loss before overhead, payroll, taxes, and interest of (119.37 M). | |
| Intech Biopharm generates negative cash flow from operations | |
| About 47.0% of the company shares are owned by insiders or employees |
Additional Tools for Intech Stock Analysis
When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.